...
首页> 外文期刊>Transplant immunology >Deletion of na?ve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.
【24h】

Deletion of na?ve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

机译:用毒素偶联的肽-MHC I类四聚体删除识别次要组织相容性抗原HY的幼稚T细胞可抑制同源CTL反应并改变免疫优势。

获取原文
获取原文并翻译 | 示例
           

摘要

Alloreactive T-cell responses directed against minor histocompatibility (H) antigens, which arise from diverse genetic disparities between donor and recipient outside the MHC, are an important cause of rejection of MHC-matched grafts. Because clinically significant responses appear to be directed at only a few antigens, the selective deletion of na?ve T cells recognizing donor-specific, immunodominant minor H antigens in recipients before transplantation may be a useful tolerogenic strategy. We have previously demonstrated that peptide-MHC class I tetramers coupled to a toxin can efficiently eliminate specific TCR-transgenic T cells in vivo. Here, using the minor histocompatibility antigen HY as a model, we investigated whether toxic tetramers could inhibit the subsequent priming of the two H2-D(b)-restricted, immunodominant T-cell responses by deleting precursor CTL. Immunization of female mice with male bone marrow elicited robust CTL activity against the Uty and Smcy epitopes, with Uty constituting the major response. As hypothesized, toxic tetramer administration prior to immunization increased survival of cognate peptide-pulsed cells in an in vivo CTL assay, and reduced the frequency of corresponding T cells. However, tetramer-mediated decreases in either T-cell population magnified CTL responses against the non-targeted epitope, suggesting that D(b)-Uty(+) and D(b)-Smcy(+) T cells compete for a limited common resource during priming. Toxic tetramers conceivably could be used in combination to dissect manipulate CD8(+) T-cell immunodominance hierarchies, and to prevent the induction of donor-specific, minor H antigen CTL responses in allotransplantation.
机译:针对次要组织相容性(H)抗原的同种反应性T细胞反应是MHC匹配移植物排斥的重要原因,这是MHC外部供体和受体之间遗传差异很大的原因。由于临床上显着的应答似乎仅针对少数几种抗原,因此在移植前选择性删除接受者中识别供体特异性,免疫显性次要H抗原的幼稚T细胞可能是有用的致耐受性策略。我们以前已经证明,与毒素偶联的I类肽MHC四聚体可以在体内有效消除特定的TCR转基因T细胞。在这里,使用次要的组织相容性抗原HY作为模型,我们研究了毒性四聚体是否可以通过删除前体CTL来抑制随后的两个H2-D(b)限制性免疫为主的T细胞反应的启动。用雄性骨髓对雌性小鼠进行免疫诱导了针对Uty和Smcy表位的强大CTL活性,其中Uty构成主要反应。如所假设的,在免疫前施用毒性四聚体在体内CTL测定中增加了同源肽脉冲细胞的存活,并降低了相应T细胞的频率。但是,四聚体介导的任一T细胞群体的减少都会放大针对非靶向表位的CTL反应,这表明D(b)-Uty(+)和D(b)-Smcy(+)T细胞竞争有限的共同点启动过程中的资源。可以将有毒的四聚体组合使用,以剖析CD8(+)T细胞的免疫显性结构,并防止同种异体移植中诱导供体特异性的次要H抗原CTL反应。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号